Macquarie transferred coverage on Cliffs Natural to analyst Anthony Young who downgraded shares to Neutral from Outperform and lowered the price target to $1.60 from $6 on shares. Young said the domestic steel market remains weak and finds it difficult to recommend Cliffs given it produces raw materials for the industry.
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
Says will continue to buy back stock "hand over fist." Says Cleveland-Cliffs (CLF) "the only U.S. solution" for U.S. Steel (X). Says will have to "re-assess value" of U.S. Steel. Says targeting net debt to EBITDA of 2.5x. Says balance sheet in "great shape, near record liquidity." Sees CapEx ~$1B/year from 2025-2028. Comments taken from Q1 earnings conference call.
During its earnings release yesterday, Cleveland-Cliffs announced that during the first quarter, the company repurchased 30.4M CLF common shares, fully utilizing the remaining balance of $608M under the previously authorized $1B share repurchase program. The average stock purchase price for the entire program was $18.79 per share. Following the completion of the program, the Cliffs Board of Directors authorized a new share repurchase program for the company to buy back up to $1.5B of its outstanding common shares. The new program does not have a specific expiration date.